Your browser is no longer supported. Please, upgrade your browser.
VICL Vical Incorporated daily Stock Chart
VICL [NASD]
Vical Incorporated
Index- P/E- EPS (ttm)-0.67 Insider Own0.97% Shs Outstand23.86M Perf Week0.00%
Market Cap20.28M Forward P/E- EPS next Y- Insider Trans-90.47% Shs Float22.61M Perf Month-25.44%
Income-14.60M PEG- EPS next Q-0.11 Inst Own34.00% Short Float0.15% Perf Quarter-30.89%
Sales0.90M P/S22.53 EPS this Y26.00% Inst Trans-24.07% Short Ratio0.15 Perf Half Y-20.56%
Book/sh2.00 P/B0.43 EPS next Y- ROA-27.60% Target Price2.00 Perf Year-32.00%
Cash/sh1.91 P/C0.44 EPS next 5Y- ROE-29.40% 52W Range0.77 - 1.47 Perf YTD-27.97%
Dividend- P/FCF- EPS past 5Y27.00% ROI-40.30% 52W High-42.18% Beta0.28
Dividend %- Quick Ratio18.40 Sales past 5Y-26.80% Gross Margin- 52W Low10.39% ATR0.05
Employees30 Current Ratio18.40 Sales Q/Q- Oper. Margin- RSI (14)34.04 Volatility4.26% 6.37%
OptionableYes Debt/Eq0.00 EPS Q/Q27.60% Profit Margin- Rel Volume1.20 Prev Close0.83
ShortableYes LT Debt/Eq0.00 EarningsAug 01 BMO Payout- Avg Volume217.06K Price0.85
Recom3.00 SMA20-7.88% SMA50-20.02% SMA200-26.51% Volume258,883 Change2.41%
Jun-12-17Resumed Rodman & Renshaw Buy $9
Jul-19-16Resumed H.C. Wainwright Buy $12
Jun-23-15Downgrade ROTH Capital Buy → Neutral $4.65 → $1.65
Jun-12-15Initiated H.C. Wainwright Buy $2.50
Jun-02-15Initiated ROTH Capital Buy $4.65
Sep-21-12Initiated Canaccord Genuity Buy $7
Dec-01-11Initiated Global Hunter Securities Buy $9
Jun-12-09Initiated Thomas Weisel Overweight $5
Nov-25-08Initiated Noble Financial Buy $5
Jun-12-19 01:45PM  SHAREHOLDER ALERT: WeissLaw LLP Investigates Vical Incorporated Acquisition PR Newswire
Jun-03-19 04:57PM  Boulder biotech firm enters reverse merger valued at up to $60 million American City Business Journals -19.13%
03:00AM  Vical and Brickell Announce Merger Agreement GlobeNewswire
Apr-25-19 10:33AM  Will Vical (VICL) Report Negative Q1 Earnings? What You Should Know Zacks
Mar-01-19 07:48AM  Vical Inc (VICL) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Feb-19-19 06:38PM  Vical: 4Q Earnings Snapshot Associated Press
05:45PM  Vical to Discontinue Clinical Development of VL-2397 as it Considers Near Term Strategic Alternatives GlobeNewswire
Dec-12-18 12:22PM  What Investors Should Know About Vical Incorporateds (NASDAQ:VICL) Financial Strength Simply Wall St.
Nov-01-18 08:15AM  New Research: Key Drivers of Growth for Interface, USA Truck, Weingarten Realty Investors, Unum Group, Trivago N.V. ADS, and Vical Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Oct-29-18 07:50AM  Vical (VICL) Reports Q3 Loss, Misses Revenue Estimates Zacks
06:43AM  Vical: 3Q Earnings Snapshot Associated Press
06:30AM  Vical Reports Third Quarter 2018 Financial and Operational Results GlobeNewswire
Oct-15-18 10:30AM  Vical (VICL) Q3 Earnings Preview: What to Know Ahead of the Release Zacks
Oct-09-18 02:03PM  Who Are The Major Shareholders In Vical Incorporated (NASDAQ:VICL)? Simply Wall St.
Aug-23-18 08:00AM  Vical to Present at the 20th Annual Rodman & Renshaw Global Investment Conference GlobeNewswire
Aug-07-18 08:25AM  Factors of Influence in 2018, Key Indicators and Opportunity within Vical, Hilton Grand Vacations, Kemper, Franklin Financial Network, Perficient, and Westinghouse Air Brake Technologies New Research Emphasizes Economic Growth GlobeNewswire
07:55AM  Vical (VICL) Reports Q2 Loss, Tops Revenue Estimates Zacks
06:48AM  Vical: 2Q Earnings Snapshot Associated Press
06:30AM  Vical Reports Second Quarter 2018 Financial and Operational Results GlobeNewswire
Jul-19-18 06:00AM  Vical Announces Review of Potential Strategic Transactions GlobeNewswire +8.26%
Jun-27-18 11:18AM  When Will Vical Incorporated (NASDAQ:VICL) Become Profitable? Simply Wall St.
Jun-11-18 07:28AM  Vical to scrap genital herpes treatment program after trial fails primary endpoint MarketWatch -26.05%
06:00AM  Vical Reports Phase 2 Trial of HSV-2 Therapeutic Vaccine Did Not Meet Primary Endpoint GlobeNewswire
May-15-18 08:35PM  Does Vical Incorporateds (NASDAQ:VICL) Past Performance Indicate A Weaker Future? Simply Wall St.
May-08-18 07:43PM  Edited Transcript of VICL earnings conference call or presentation 3-May-18 4:00pm GMT Thomson Reuters StreetEvents
May-03-18 06:39AM  Vical: 1Q Earnings Snapshot Associated Press
06:30AM  Vical Reports First Quarter 2018 Financial and Operational Results GlobeNewswire
May-02-18 07:45AM  Market Trends Toward New Normal in City Office REIT, Malibu Boats, Vical, Renasant, Genocea Biosciences, and Lindsay Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Apr-26-18 04:05PM  Vical Announces News Release and Conference Call Schedule for First Quarter 2018 Financial Results GlobeNewswire
Mar-19-18 08:00AM  Analysis: Positioning to Benefit within ICF International, Invitae, Encore Wire, Alexandria Real Estate Equities, Syndax Pharmaceuticals, and Vical Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Mar-15-18 11:11PM  Edited Transcript of VICL earnings conference call or presentation 15-Mar-18 4:00pm GMT Thomson Reuters StreetEvents -5.00%
09:00AM  Vical Incorporated to Host Earnings Call ACCESSWIRE
06:47AM  Vical reports 4Q loss Associated Press
06:30AM  Vical Reports Fourth Quarter 2017 Financial and Operational Results GlobeNewswire
Mar-08-18 09:07PM  Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2017 Financial Results GlobeNewswire
Feb-20-18 06:00AM  Vical Initiates Phase 2 Trial of VL-2397 Antifungal for Invasive Aspergillosis GlobeNewswire
Feb-01-18 06:30AM  Vical and Mycoses Study Group Education and Research Consortium Establish Collaboration to Advance Vicals Novel Antifungal VL-2397 for the Treatment of Invasive Aspergillosis GlobeNewswire
Jan-30-18 04:15PM  Vical Announces Restructuring to Focus Resources on HSV-2 and Antifungal Clinical Programs GlobeNewswire
Jan-29-18 10:17AM  Motif Bio PLC, Spero Therapeutics, Inc. and Vical Incorporated Join Antimicrobials Working Group PR Newswire +6.99%
Jan-22-18 03:00AM  Astellas and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients PR Newswire -22.99%
Jan-08-18 08:30AM  Detailed Research: Economic Perspectives on US Ecology, Vical, Armstrong World Industries, TriCo Bancshares, HealthStream, and Neogen What Drives Growth in Today's Competitive Landscape GlobeNewswire
Dec-12-17 04:34PM  What You Must Know About Vical Incorporateds (undefined:VICL) Financial Health Simply Wall St.
Dec-04-17 05:40PM  Want To Invest In Vical Incorporated (VICL)? Heres How It Performed Lately Simply Wall St.
Nov-24-17 08:58AM  Are Options Traders Betting on a Big Move in Vical (VICL) Stock? Zacks
Nov-21-17 12:20PM  ETFs with exposure to Vical, Inc. : November 21, 2017 Capital Cube
Nov-08-17 06:30AM  Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock GlobeNewswire +10.24%
Nov-06-17 12:41PM  ETFs with exposure to Vical, Inc. : November 6, 2017 Capital Cube -13.81%
Oct-26-17 10:53AM  ETFs with exposure to Vical, Inc. : October 26, 2017 Capital Cube
Oct-25-17 08:35AM  Vical, Inc. :VICL-US: Earnings Analysis: Q3, 2017 By the Numbers : October 25, 2017 Capital Cube
Oct-24-17 12:00PM  Edited Transcript of VICL earnings conference call or presentation 23-Oct-17 4:00pm GMT Thomson Reuters StreetEvents
06:30AM  Vical Announces Joint Development Program With AnGes on a Treatment for Chronic Hepatitis B Infection GlobeNewswire
Oct-23-17 06:37AM  Vical reports 3Q loss Associated Press
06:30AM  Vical Reports Third Quarter 2017 Financial and Operational Results GlobeNewswire
Oct-16-17 05:30PM  Vical Announces News Release and Conference Call Schedule for Third Quarter 2017 Financial Results GlobeNewswire
Oct-13-17 04:05PM  Vical to Provide Company Update at BIO Investor Forum Conference GlobeNewswire
Oct-11-17 12:09PM  ETFs with exposure to Vical, Inc. : October 11, 2017 Capital Cube
Oct-10-17 06:30AM  Vical Announces Completion of the Phase 3 ASP0113 CMV Vaccine Trial GlobeNewswire +7.22%
Oct-02-17 04:15PM  Vical Announces that its Antifungal VL-2397 is Eligible for Limited Use Indication Approval by FDA Based on a Single Phase 2 Efficacy Trial GlobeNewswire +6.67%
Sep-28-17 06:00AM  Vical to Present at IDWeek and the 8th Trends in Medical Mycology Conferences GlobeNewswire
Sep-14-17 07:24PM  ETFs with exposure to Vical, Inc. : September 14, 2017 Capital Cube
Sep-13-17 11:30AM  Vical, Inc. :VICL-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017 Capital Cube
Sep-12-17 09:40AM  Edited Transcript of VICL earnings conference call or presentation 8-Aug-17 4:00pm GMT Thomson Reuters StreetEvents
Sep-06-17 03:00PM  Vical to Present at the Rodman & Renshaw 19th Annual Global Investment Conference GlobeNewswire
Aug-08-17 04:43PM  Vical reports 2Q loss Associated Press -5.02%
09:40AM  Investor Network Invites You to the Vical Second Quarter 2017 Earnings Webcast Live on Tuesday, August 8, 2017 ACCESSWIRE
08:50AM  Investor Network: Vical Incorporated to Host Earnings Call ACCESSWIRE
06:30AM  Vical Reports Second Quarter 2017 Financial and Operational Results GlobeNewswire
Aug-01-17 04:05PM  Vical Announces News Release and Conference Call Schedule for Second Quarter 2017 Financial Results GlobeNewswire
Jun-30-17 03:32PM  ETFs with exposure to Vical, Inc. : June 30, 2017 Capital Cube
Jun-15-17 04:05PM  Vical to Provide Company Update at the 2017 BIO International Convention GlobeNewswire
Jun-14-17 01:54PM  ETFs with exposure to Vical, Inc. : June 14, 2017 Capital Cube
Jun-13-17 10:10AM  Vical, Inc. :VICL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017 Capital Cube
Jun-05-17 06:30AM  Vical Presents Phase 1 VL-2397 Data at the June ASM Microbe 2017 Meeting Supporting Advancement to Phase 2 GlobeNewswire
May-23-17 06:30AM  Vical to Present VL-2397 Data at the June ASM Microbe 2017 Meeting GlobeNewswire
May-21-17 10:50PM  Edited Transcript of VICL earnings conference call or presentation 15-May-17 4:00pm GMT Thomson Reuters StreetEvents
May-15-17 09:00AM  Investor Network: Vical Incorporated to Host Earnings Call Accesswire
07:03AM  Vical reports 1Q loss Associated Press
06:30AM  Vical Reports First Quarter 2017 Financial Results GlobeNewswire
May-12-17 04:05PM  Investor Network Invites You to the Vical First Quarter 2017 Earnings Webcast Live on Monday, May 15, 2017 Accesswire
May-08-17 06:30AM  Vical Announces News Release and Conference Call Schedule for First Quarter 2017 Financial Results GlobeNewswire
May-02-17 04:36PM  Vical Highlights Successful Outcome of Phase 1 Trial of VL-2397 Novel Antifungal During its Research and Development Day GlobeNewswire
Apr-24-17 06:30AM  Vical to Host Virtual Research & Development Day on May 2, 2017 GlobeNewswire
Apr-19-17 06:30AM  Vical Completes Target Enrollment in Its Phase 2 Therapeutic HSV-2 Vaccine Trial GlobeNewswire
Apr-05-17 05:40PM  ETFs with exposure to Vical, Inc. : April 5, 2017 Capital Cube
Mar-16-17 01:04PM  VICAL INC Financials
Mar-15-17 09:26AM  Vical, Inc. :VICL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 15, 2017 Capital Cube
Mar-10-17 04:04PM  VICAL INC Files SEC form 10-K, Annual Report
06:30AM  Vical to Provide Company Update at the 29th Annual ROTH Conference GlobeNewswire
Mar-09-17 07:23AM  VICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:07AM  Q4 2016 Vical Inc Earnings Release - Before Market Open
07:00AM  Vical to Provide Company Update at BIO Asia International Conference GlobeNewswire
06:43AM  Vical reports 4Q loss Associated Press
06:30AM  Vical Reports Fourth Quarter 2016 Financial Results GlobeNewswire
Mar-08-17 04:10PM  Investor Network Invites You to the Vical Fourth Quarter 2016 Earnings Webcast Live on Thursday, March 9, 2017 Accesswire
Mar-02-17 06:30AM  Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2016 Financial Results GlobeNewswire
Feb-24-17 03:00PM  Vical Provides Company Update at Biocom's Global Life Science Partnering Conference GlobeNewswire
Feb-07-17 06:30AM  Vical Provides Company Update at BIO CEO and Investor Conference GlobeNewswire
Jan-06-17 12:17PM  ETFs with exposure to Vical, Inc. : January 6, 2017
Dec-13-16 01:40PM  ETFs with exposure to Vical, Inc. : December 13, 2016
Nov-07-16 01:07PM  ETFs with exposure to Vical, Inc. : November 7, 2016
Vical Incorporated researches and develops biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The company was founded in 1987 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARMISTICE CAPITAL, LLC10% OwnerJan 10Sale0.882,190,5001,930,7072,170,000Jan 14 05:52 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 28Buy1.211,276,5911,538,9814,360,500Jul 02 05:44 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 27Buy1.2332,03039,3523,083,909Jun 27 05:14 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 26Buy1.249,10311,3223,051,879Jun 27 05:14 PM